Market Research Logo

Ophthalmology Drugs Market Global Report 2017 Including: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)Covering: Novartis AG, Regeneron, Allergan, F. Hoffmann-La Roche Ltd, and Pfizer Inc

Ophthalmology Drugs Market Global Report 2017 Including: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)Covering: Novartis AG, Regeneron, Allergan, F. Hoffmann-La Roche Ltd, and Pfizer Inc.

Development of combination therapies for the treatment of eye related diseases including glaucoma is an emerging trend in the market. For instance, in September 2013, Alcon (a subsidiary of Novartis) received FDA approval for commercialization of its Simbrinza, a fixed dose combination drug without beta blocker used for the treatment of glaucoma.

The Ophthalmology Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs sector.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the ophthalmology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The ophthalmology drugs market section of the report gives context. It compares the ophthalmology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Ophthalmology Drugs Indicators Comparison.
  • The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope

Markets Covered: Glaucoma, Dry Eye, Others (Retinal Disorders, Anti-Infectives/Allergy)

Companies Mentioned: Novartis AG, Regeneron, Allergan, F. Hoffmann-La Roche Ltd, and Pfizer Inc.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Ophthalmology Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Ophthalmology Drugs Market Characteristics
2. Ophthalmology Drugs Market Size And Growth
2.1. Historic Market Growth
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market
3. Pestle Analysis
3.1. Political
3.2. Economic
3.3. Social
3.4. Technological
3.5. Legal
3.6. Environmental
4. Ophthalmology Drugs Market Customer Information
5. Ophthalmology Drugs Market Segmentation
5.1. Global Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
5.2. Global Ophthalmology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment
5.3 Global Ophthalmology Drugs Market Trends And Strategies
6. Ophthalmology Drugs Market Regional And Country Analysis
6.1. Global Ophthalmology Drugs Market, 2016, By Region
6.2. Global Ophthalmology Drugs Market, 2012 - 2020, Historic And Forecast, By Region
6.3. Ophthalmology Drugs Market, 2016, By Country
6.4. Ophthalmology Drugs Market, 2012 - 2020, Historic And Forecast, By Country
6.5. Global Pharmaceutical Market Segments, 2016, By Region
6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region
6.7. Global Pharmaceutical Market Segments, 2016, By Country
6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country
7. Global Ophthalmology Drugs Market Comparison With Macro Economic Factors
7.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global
7.2. Per Capita Average Ophthalmology Drugs Expenditure, Global
8. Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries
8.1. Ophthalmology Drugs Market Size, Percentage Of GDP, By Country
8.2. Per Capita Average Ophthalmology Drugs Expenditure, By Country
9. Ophthalmology Drugs Market Comparison With Industry Metrics
9.1. Global Number Of Pharmacists, 2016, By Country
9.2. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country
9.3. Global Number Of Pharma Enterprises, 2016, By Country
9.4. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
9.5. Global Average Spending On R&D/Product Development, 2016, By Country
9.6. Global Ophthalmology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.8. Global Ophthalmology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.9. Prevalent Cases Of Glaucoma, 2014, By Country
10. Asia-Pacific Ophthalmology Drugs Market
10.1.1. Asia-Pacific Ophthalmology Drugs Market Overview
10.1.2. Asia-Pacific Ophthalmology Drugs Historic Market, 2012 - 2016
10.1.3. Asia-Pacific Ophthalmology Drugs Forecast Market, 2016 - 2020
10.1.4. Asia-Pacific Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
10.2. Asia-Pacific Ophthalmology Drugs Market: Country Analysis
10.3. China Ophthalmology Drugs Market
10.3.1. China Ophthalmology Drugs Market Overview
10.3.2. China Ophthalmology Drugs Historic Market, 2012 - 2016
10.3.3. China Ophthalmology Drugs Forecast Market, 2016 - 2020
10.3.4. China Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
10.3.5. China Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
10.3.6. China Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
10.4. India Ophthalmology Drugs Market
10.4.1. India Ophthalmology Drugs Market Overview
10.4.2. India Ophthalmology Drugs Historic Market, 2012 - 2016
10.4.3. India Ophthalmology Drugs Forecast Market, 2016 - 2020
10.4.4. India Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
10.4.5. India Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
10.4.6. India Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
10.5. Japan Ophthalmology Drugs Market
10.5.1. Japan Ophthalmology Drugs Market Overview
10.5.2. Japan Ophthalmology Drugs Historic Market, 2012 - 2016
10.5.3. Japan Ophthalmology Drugs Forecast Market, 2016 - 2020
10.5.4. Japan Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
10.5.5. Japan Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
10.5.6. Japan Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
10.6. Australia Ophthalmology Drugs Market
10.6.1. Australia Ophthalmology Drugs Historic Market, 2012 - 2016
10.6.2. Australia Ophthalmology Drugs Forecast Market, 2016 - 2020
10.6.3. Australia Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
10.6.4. Australia Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
10.6.5. Australia Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
11. Western Europe Ophthalmology Drugs Market
11.1.1. Western Europe Ophthalmology Drugs Market Overview
11.1.2. Western Europe Ophthalmology Drugs Historic Market, 2012 - 2016
11.1.3. Western Europe Ophthalmology Drugs Forecast Market, 2016 - 2020
11.1.4. Western Europe Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
11.2. Western Europe Ophthalmology Drugs Market: Country Analysis
11.3. UK Ophthalmology Drugs Market
11.3.1. UK Ophthalmology Drugs Market Overview
11.3.2. UK Ophthalmology Drugs Historic Market, 2012 - 2016
11.3.3. UK Ophthalmology Drugs Forecast Market, 2016 - 2020
11.3.4. UK Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
11.3.5. UK Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
11.3.6. UK Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
11.4. Germany Ophthalmology Drugs Market
11.4.1. Germany Ophthalmology Drugs Historic Market, 2012 - 2016
11.4.2. Germany Ophthalmology Drugs Forecast Market, 2016 - 2020
11.4.3. Germany Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
11.4.4 Germany Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
11.4.5 Germany Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
11.5 France Ophthalmology Drugs Market
11.5.1 France Ophthalmology Drugs Historic Market, 2012 - 2016
11.5.2 France Ophthalmology Drugs Forecast Market, 2016 - 2020
11.5.3 France Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
11.5.4 France Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
11.5.5 France Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
11.6. Italy Ophthalmology Drugs Market
11.6.1. Italy Ophthalmology Drugs Historic Market, 2012 - 2016
11.6.2. Italy Ophthalmology Drugs Forecast Market, 2016 - 2020
11.6.3. Italy Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
11.6.4. Italy Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
11.6.5. Italy Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
11.7. Spain Ophthalmology Drugs Market
11.7.1. Spain Ophthalmology Drugs Historic Market, 2012 - 2016
11.7.2. Spain Ophthalmology Drugs Forecast Market, 2016 - 2020
11.7.3. Spain Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
11.7.4. Spain Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
11.7.5. Spain Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
12. Eastern Europe Ophthalmology Drugs Market
12.1.1. Eastern Europe Ophthalmology Drugs Market Overview
12.1.2. Eastern Europe Ophthalmology Drugs Historic Market, 2012 - 2016
12.1.3. Eastern Europe Ophthalmology Drugs Forecast Market, 2016 - 2020
12.1.4 Eastern Europe Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
12.2. Eastern Europe Ophthalmology Drugs Market: Country Analysis
12.3. Russia Ophthalmology Drugs Market
12.3.1. Russia Ophthalmology Drugs Historic Market, 2012 - 2016
12.3.2. Russia Ophthalmology Drugs Forecast Market, 2016 - 2020
12.3.3. Russia Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
12.3.4. Russia Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
12.3.5. Russia Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
13. North America Ophthalmology Drugs Market
13.1.1. North America Ophthalmology Drugs Market Overview
13.1.2. North America Ophthalmology Drugs Historic Market, 2012 - 2016
13.1.3. North America Ophthalmology Drugs Forecast Market, 2016 - 2020
13.1.4. North America Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
13.2. North America Ophthalmology Drugs Market: Country Analysis
13.3. USA Ophthalmology Drugs Market
13.3.1. USA Ophthalmology Drugs Historic Market, 2012 - 2016
13.3.2. USA Ophthalmology Drugs Forecast Market, 2016 - 2020
13.3.3 USA Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
13.3.4. USA Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
13.3.5. USA Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
14. South America Ophthalmology Drugs Market
14.1.1. South America Ophthalmology Drugs Market Overview
14.1.2. South America Ophthalmology Drugs Historic Market, 2012 - 2016
14.1.3. South America Ophthalmology Drugs Forecast Market, 2016 - 2020
14.1.4. South America Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
14.2. South America Ophthalmology Drugs Market: Country Analysis
14.3. Brazil Ophthalmology Drugs Market
14.3.1. Brazil Ophthalmology Drugs Historic Market, 2012 - 2016
14.3.2. Brazil Ophthalmology Drugs Forecast Market, 2016 - 2020
14.3.3. Brazil Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
14.3.4. Brazil Ophthalmology Drugs Percentage Of GDP, 2012 - 2020
14.3.5. Brazil Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020
15. Middle East Ophthalmology Drugs Market
15.1.1. Middle East Ophthalmology Drugs Market Overview
15.1.2. Middle East Ophthalmology Drugs Historic Market, 2012 - 2016
15.1.3. Middle East Ophthalmology Drugs Forecast Market, 2016 - 2020
15.1.4. Middle East Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
16. Africa Ophthalmology Drugs Market
16.1.1. Africa Ophthalmology Drugs Market Overview
16.1.2. Africa Ophthalmology Drugs Historic Market, 2012 - 2016
16.1.3. Africa Ophthalmology Drugs Forecast Market, 2016 - 2020
16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment
16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
17. Ophthalmology Drugs Market Competitive Landscape
17.1. Company Profiles
17.2. Novartis Ag
17.2.1. Overview
17.2.2. Products And Services
17.2.3. Strategy
17.2.4. Financial Performance
17.3. Regeneron
17.3.1. Overview
17.3.2. Products And Services
17.3.3. Strategy
17.3.4. Financial Performance
17.4. Allergan
17.4.1. Overview
17.4.2. Products And Services
17.4.3. Strategy
17.4.4. Financial Performance
17.5. F. Hoffmann-La Roche Ltd
17.5.1. Overview
17.5.2. Products And Services
17.5.3. Strategy
17.5.4. Financial Performance
17.6. Pfizer Inc.
17.6.1. Overview
17.6.2. Products And Services
17.6.3. Strategy
17.6.4. Financial Performance
18. Key Mergers And Acquisitions In The Ophthalmology Drugs Market
19. Market Background: Pharmaceutical Drugs Market
19.1.1. Pharmaceutical Drugs Market Characteristics
19.1.2. Pharmaceutical Drugs Market Historic Growth
19.1.2.1. Drivers Of The Market
19.1.2.2. Restraints Of The Market
19.1.3. Pharmaceutical Drugs Market Forecast Growth
19.1.3.1. Drivers Of The Market
19.1.3.2. Restraints Of The Market
19.1.4. Pharmaceutical Drugs Trends And Strategies
19.2. Pharmaceutical Drugs Market Regional And Country Analysis
19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region
19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region
19.2.3. Pharmaceutical Drugs Market, 2016, By Country
19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country
19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment
19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment
19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors
19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global
19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global
19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country
19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
21.1. NAICS Definitions Of Industry Covered In This Report
21.2. Abbreviations
21.3. Currencies
21.4. Research Inquiries
21.5. The Business Research Company
21.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report